“national-cancer-institute” Archives

in
Entry Author Date Location
Dallas-Based Peloton Raises $52.4M for Kidney Cancer Drug Candidate 09/15/16 Texas
UW-Madison Awarded $12M NCI Grant to Study Cellectar Cancer Drug 09/14/16 Wisconsin
Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap 09/09/16 National
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Brookings Report, Imbed, & Coinigy: This Week’s Wisconsin Watchlist 08/08/16 Wisconsin
National Cancer Institute Awards Cellectar $2M For Clinical Study 08/05/16 Wisconsin
Strata Oncology Closes $12M Round, Aims to Increase Tumor Sequencing 06/06/16 Detroit Ann Arbor
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
In Immuno-Oncology’s Latest Win, FDA OK’s Genentech Drug 05/18/16 San Francisco
San Antonio Cancer Center Aims for Elegance in Treatment, Prevention 03/11/16 Texas
Seven Bridges Gets $45M, Begins Test Run for Cancer Genomics Tool 02/16/16 Boston
Wisconsin Roundup: Exact Sciences, Cellectar, BrightStar, & More 10/01/15 Wisconsin
Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO 08/24/15 Texas
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? 08/04/15 National
TX Roundup: New Funding, an IPO, Rice Biz Plan winner, & More 04/27/15 Texas
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials 04/15/15 Raleigh Durham
Startups Strut on Stage at UNC Innovation Showcase 04/10/15 Raleigh Durham
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
Tracon Files for $57.5M IPO to Move Cancer Drugs to Next Stage 01/06/15 San Diego
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
Patient Deaths Move Amgen To Pull Drug From Stomach Cancer Trials 11/24/14 Seattle
TeVido Taps 3D Printing Technology to Build a Better Nipple 10/30/14 Texas
BioPharma Learns From Marvel, Begins Real Life Search For “X-Men” 04/30/14 Seattle
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
ApoCell Entering the Commercial Ring In Rare Tumor Cell Diagnostics 12/24/13 San Francisco
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Page 2 of 4 « previous page · next page »